Form 4 for EDIT Editas Medicine, Inc.
Accepted 2021-12-23 00:00:00 ET · period of report 2021-12-22 · accession 0001179110-21-011223 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-23 | 2021-12-22 | EDIT | MULLEN JAMES C | CEO, Dir | A - Grant | $0.00 | +36.5K | 94.2K | +63% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-22 | A | A | 36,477 | $0.00 | 94,150 | D | — | — |